Among the different STATs, STAT3 and STAT5 are often constitutively active in various human cancers, including renal cell carcinoma (RCC) [4–6], and control the expression of multiple genes involved in initiation, progression and chemoresistance [7–9]. This evidence concerns the gene STAT5A and renal cell carcinoma.